Company: LRHC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014247
Chunk: 18

Company: La Rosa Holdings Corp.
Filing Date: 2025-02-14
Form: S-1
Chunk 18
---
 of Proceeds                         |     | We                                                                                                                                       
 will not receive any of the proceeds from the sale of the common stock registered hereunder. We will receive proceeds upon exercise      
 of the Incremental Warrants. We intend to use such proceeds for general corporate purposes and working capital requirements and other    
 purposes that the Board of Directors deems to be in the best interests of the Company.                                                   |
| Risk                                
 Factors                             |     | An                                                                                                                                       
 investment in our common stock involves a high degree of risk and could result in a loss of your entire investment. Further, the         
 issuance to, or sale by, the Selling Stockholder of a significant amount of shares being registered in the registration statement,       
 of which this prospectus forms a part, at any given time could cause the market price of our common stock to decline and to be highly    
 volatile, and we do not have the right to control the timing and amount of any sales by the Selling Stockholder of such shares. Prior    
 to making an investment decision, you should carefully consider all of the information in this Prospectus and, in particular, you        
 should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 11.                                        |
| Trading                             
 Symbol on the Nasdaq Capital Market |     | LRHC                                                                                                                                     |

| (1) | Based                                                                                                                                 
 on 32,273,532 shares of common stock outstanding as of February 12, 2025. Other than the shares of common stock underlying the Notes, 
 it excludes the following as of such date:                                                                                            |

| ● | 1,445,453 shares of our common stock issuable upon the exercise of warrants outstanding, at a weighted average exercise price of $1.11 per share; |

| ● | 4,252,161 shares of our common stock issuable upon the exercise of stock options outstanding, at a weighted average exercise price of $1.51 per share; |

| ● | 98,524 shares of our common stock issuable upon the vesting of restricted stock units; and |

| ● | 16,539,053 shares of our common stock reserved for future issuance under our Amended and Restated 2022 Equity Incentive Plan. |

<div align='center'>10

RISK FACTORS</div>

The risks and uncertainties described therein and below could materially adversely affect our business, operating results and financial condition, as well as cause the value of our securities to decline. You may lose all or part of your investment